Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03946618 · ClinicalTrials.gov registry record · NA
Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy
A NA study of Epilepsy, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03946618: Active NA study of Epilepsy, sponsored by Mayo Clinic.
NCT03946618 is a NA study of Epilepsy that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 5 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03946618, a NA study of Epilepsy, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine if tracking seizure occurrence, seizure probability, behavioral state, cognition, and mood can be achieved using an implantable brain sensing and stimulation device (Medtronic RC+S Summit) coupled to an external, handheld, patient assistant device (PAD) with capability for patient interaction (patient data input). The system (RC+S \& PAD) provides intracranial EEG (iEEG) sensing, electrical brain stimulation, and machine learning algorithms running on the RC+S and PAD that will be coupled with electrical brain stimulation (EBS) to prevent seizures and improve quality of life in patients with epilepsy.
Primary Outcome
Number of AEs reported
Conditions Studied
Interventions
- DEVICE Medtronic Summit System, Olympus
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-01-18 |
| Est. Completion | 2027-02 |
| Phase | NA |
What the registry record for NCT03946618 still lists
NCT03946618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Summit System, Olympus is the first listed.
NCT03946618 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03946618 about?
NCT03946618 is a clinical study titled "Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy". Researchers are trying to determine if tracking seizure occurrence, seizure probability, behavioral state, cognition, and mood can be achieved using an implantable brain sensing and stimulation device (Medtronic RC+S Summit) coupled to an external, handheld, patient assistant device (PAD) with capab...
What is the current status of trial NCT03946618?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2019-01-18. Estimated completion is 2027-02.
What conditions does trial NCT03946618 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT03946618?
The interventions under investigation include: Medtronic Summit System, Olympus (DEVICE).
Who is sponsoring clinical trial NCT03946618?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03946618 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03946618's enrollment target sits among peer trials
5 156th of 160 higher than 2 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI